Bath & Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Bath & Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Bath & Body Works shares gained 0.8% to close at $30.75 on Thursday.Bath & Body Works, Inc. (NYSE:BBWI) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 25.
巴斯与身体工坊公司（纽交所：BBWI）将于11月25日星期一开盘前发布第三季度的财报。
Analysts expect Bath & Body Works to report quarterly earnings at 47 cents per share. That's down from 48 cents per share a year ago. The Columbus, Ohio-based company projects to report quarterly revenue of $1.58 billion, compared to $1.56 billion a year earlier, according to data from Benzinga Pro.
分析师预计巴斯与身体工坊的季度每股收益为47美分，低于去年的48美分。这家位于俄亥俄州哥伦布的公司预计季度营业收入为15.8亿美元，而去年为15.6亿美元，根据Benzinga Pro的数据。
On Nov. 8, Bath & Body Works announced the declaration of its regular quarterly dividend of 20 cents per share payable on Dec. 6, to shareholders of record at the close of business on Nov. 22.
11月8日，巴斯与身体工坊宣布将于12月6日向11月22日收盘时登记者支付每股20美分的常规季度股息。
Bath & Body Works shares gained 0.8% to close at $30.75 on Thursday.
巴斯与身体工坊的股票在星期四上涨了0.8%，收盘价为30.75美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga读者可以在分析师股票评级页面上查看最新的分析师评级。读者可以按股票代码、公司名称、分析机构、评级变动或其他变量进行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
让我们来看看Benzinga最准确的分析师们是如何在最近一段时间内评价这家公司的。
- Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and cut the price target from $35 to $32 on Nov. 6. This analyst has an accuracy rate of 66%.
- BMO Capital analyst Simon Siegel reiterated an Outperform rating and lowered the price target from $52 to $50 on Aug. 29. This analyst has an accuracy rate of 75%.
- Goldman Sachs analyst Kate McShane maintained a Buy rating and cut the price target from $60 to $49 on Aug. 29. This analyst has an accuracy rate of 69%.
- JP Morgan analyst Matthew Boss maintained a Neutral rating and slashed the price target from $42 to $39 on Aug. 29. This analyst has an accuracy rate of 67%.
- Raymond James analyst Olivia Tong maintained a Neutral rating and cut the price target from $51 to $42 on Aug. 29. This analyst has an accuracy rate of 66%.
- 富国银行分析师艾克·博鲁乔夫维持中立评级，并于11月6日将目标价从35美元下调至32美元。该分析师的准确率为66%。
- BMO资本分析师西蒙·西格尔重申了跑赢大盘的评级，并于8月29日将目标价从52美元下调至50美元。该分析师的准确率为75%。
- 高盛分析师凯特·麦克谢恩在8月29日维持了买入评级，并将目标价从60美元下调至49美元。该分析师的准确率为69%。
- 摩根大通分析师马修·博斯在8月29日维持了中立评级，并将目标价从42美元下调至39美元。该分析师的准确率为67%。
- 雷蒙德·詹姆斯分析师奥利维亚·汤在8月29日维持了中立评级，并将目标价从51美元下调至42美元。该分析师的准确率为66%。
Considering buying BBWI stock? Here's what analysts think:
考虑购买BBWI股票吗？以下是分析师的看法：
Read This Next:
Read This Next:
- Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
- 华尔街最准确的分析师对3只超过5%股息收益率的医疗保健股票发表看法
